Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News XenoPort XNPT

Healthcare Biotechnology
"XenoPort Inc is a biopharmaceutical company. It is engaged in developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological and other disorders."

Recent & Breaking News (NDAQ:XNPT)

Dr. Reddy's Laboratories and XenoPort Enter into a U.S. Licensing Agreement for XP23829

Business Wire March 28, 2016

#StopMakingExcuses Awareness Campaign for Restless Legs Syndrome Launches During Sleep Awareness Week 2016

Business Wire March 7, 2016

XenoPort to Present at the Cowen and Company 36th Annual Health Care Conference

Business Wire March 1, 2016

XenoPort Reports Fourth Quarter and Year-End 2015 Financial Results

Business Wire February 25, 2016

XenoPort to Release Fourth Quarter and Year-End Financial Results on February 25, 2016

Press Releases February 16, 2016

Market Influences That Drive Equities Forward - New Research on Linn Energy LLC, Xenoport, Aratana Therapeutics, and Sify Technologies

Accesswire December 28, 2015

Market Influences That Drive Equities Forward - Complementary Research on EnerNOC, Fogo De Chao, Aegion, and Xenoport

Accesswire December 14, 2015

Be On Top Of The Latest Developments - Research on MarineMax, World Acceptance, Xenoport and Stone Energy

Accesswire November 25, 2015

What does the Technical Data Say - Research on United Insurance, MarineMax, World Acceptance and Xenoport

Accesswire November 17, 2015

The Price Data Tells the Story - Research on World Acceptance, Xenoport, Stone Energy and Boot Barn Holdings

Accesswire November 10, 2015

Where Opportunity is Found - Research on Sanchez Energy, Xenoport, Aegean Marine Petroleum and REX American Resources

Accesswire November 5, 2015

XenoPort Reports Third Quarter Financial Results

Business Wire November 4, 2015

XenoPort to Present at the Credit Suisse Healthcare Conference

Business Wire October 29, 2015

XenoPort to Release Third Quarter Financial Results on November 4

Business Wire October 27, 2015

XenoPort Announces Plan to Focus on its Growing HORIZANT Business and Names Vincent J. Angotti Chief Executive Officer and Director

Business Wire October 1, 2015

XenoPort Announces Positive Phase 2 Study Results for XP23829 as a Potential Treatment for Patients with Psoriasis

Business Wire September 15, 2015

XenoPort to Present at the Morgan Stanley Global Healthcare Conference

Business Wire September 4, 2015

XenoPort to Present at the 2015 Wells Fargo Healthcare Conference

Business Wire September 2, 2015

XenoPort Reports Second Quarter Financial Results

Business Wire August 5, 2015

XenoPort to Release Second Quarter Financial Results on August 5, 2015

Business Wire July 27, 2015